CC BY 4.0Herbst, LauraLauraHerbstGroten, FerdinandFerdinandGrotenMurphy, MaryMaryMurphyShaw, GeorginaGeorginaShawNießing, BastianBastianNießingSchmitt, Robert H.Robert H.Schmitt2023-10-112023-10-112023-10-10https://publica.fraunhofer.de/handle/publica/451581https://doi.org/10.24406/publica-197710.24406/publica-197710.3390/pr11102938Induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (iMSCs) are amenable for use in a clinical setting for treatment of osteoarthritis (OA), which remains one of the major illnesses worldwide. Aside from iPSC-derived iMSCs, chondrocytes (iCHO) and extracellular vesicles (EV) are also promising candidates for treatment of OA. Manufacturing and quality control of iPSC-derived therapies is mainly manual and thus highly time consuming and susceptible to human error. A major challenge in translating iPSC-based treatments more widely is the lack of sufficiently scaled production technologies from seeding to fill-and-finish. Formerly, the Autostem platform was developed for the expansion of tissue-derived MSCs at scale in stirred tank bioreactors and subsequent fill-and-finish. Additionally, the StemCellDiscovery platform was developed to handle plate-based cultivation of adherent cells including their microscopic analysis. By combining the existing automation technology of both platforms, all required procedures can be integrated in the AutoCRAT system, designed to handle iPSC expansion, differentiation to iMSCs and iCHOs, pilot scale expansion, and formulation of iMSCs as well as extracellular vesicles and their purification. Furthermore, the platform is equipped with several in-line and at-line assays to determine product quality, purity, and safety. This paper highlights the need for adaptable and modular automation concepts. It also stresses the importance of ensuring safety of generated therapies by incorporating automated release testing and cleaning solutions in automated systems. The adapted platform concepts presented here will help translate these technologies for clinical production at the necessary scale.enStem cellsAutomationOsteoarthritisiPSCiMSCiCHOExtracellular vesiclesDDC::600 Technik, Medizin, angewandte Wissenschaften::620 IngenieurwissenschaftenDDC::600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheitjournal article